Scarica l'app Stockscreener
7.44
11.88%
0.79
Dopo l'orario di chiusura:
7.44
Capsovision Inc Borsa (CV) Ultime notizie
CapsoVision targets 510(k) submission for Gen 2 colon capsule and AI module in Q3 2026 as commercial adoption accelerates - msn.com
Major CapsoVision (CV) holder Shen Ching Hang reports large direct and indirect stake - Stock Titan
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Grows By 35.2% - marketbeat.com
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline By Investing.com - Investing.com Australia
Benchmark cuts CapsoVision stock price target to $10 on delayed timeline - Investing.com Australia
CapsoVision (NASDAQ:CV) Price Target Lowered to $10.00 at Benchmark - MarketBeat
CapsoVision 2025 Financial Performance Review - AlphaStreet
CapsoVision revenue up 13% to USD 3.9M in Q4 2025 - Medical Buyer
CapsoVision (CV) Q4 Loss Of US$0.16 EPS Tests Bullish Profitability Narratives - Sahm
CapsoVision’s CapsoCam: 360° Panoramic AI-Powered Capsule Endoscopy Solution Expanding Global GI Diagnostics Market 2324323344 - Minichart
Large CapsoVision (CV) holder discloses direct and trust share stakes - Stock Titan
CapsoVision Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: CapsoVision Q4 2025 sees revenue growth, stock dips - Investing.com Australia
CapsoVision Q4 Earnings Call Highlights - marketbeat.com
CapsoVision Inc reports results for the quarter ended September 30Earnings Summary - TradingView
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
CV: AI-powered capsule endoscopy drives growth and innovation in noninvasive GI screening - TradingView
CapsoVision 10-K: Revenue $13.6M, EPS $(1.03) — Annual Results - TradingView
CapsoVision (NASDAQ: CV) flags going concern while advancing AI colon capsule - Stock Titan
CapsoVision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
CapsoVision Faces Deadline to Turn Capital Into Profit Before Runway Collapses - Bitget
CapsoVision (NASDAQ: CV) grows 2025 revenue 15% as net loss widens - Stock Titan
CapsoVision, Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener
CapsoVision Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening - MarketBeat
CapsoVision price target raised to $11 from $7 at Roth Capital - tipranks.com
CapsoVision (CV) director receives 4,045 RSU equity award - Stock Titan
CapsoVision (CV) awards 4,045 RSUs to board director - Stock Titan
CapsoVision (CV) director receives 4,045 RSU grant as board compensation - Stock Titan
CapsoVision (CV) director receives 4,045 RSUs vesting through 2026 - Stock Titan
CapsoVision (CV) awards 4,045 restricted stock units to director - stocktitan.net
[Form 4] CapsoVision, Inc Insider Trading Activity - Stock Titan
CV: AI-powered capsule endoscopy targets multi-cancer detection with global expansion and strong funding - TradingView
CV: CapsoVision advances AI-powered capsule endoscopy with strong pipeline and global expansion - TradingView
CapsoVision’s Strategic Moves Spike Stock as Market Anticipates Growth - timothysykes.com
CapsoVision Surges 13% on Closing $14M Private Placement - StocksToTrade
CapsoVision Closes $14 Million Private Placement and Reports Preliminary 2025 Financial Results - Minichart
CapsoVision closes $14 million private placement financing By Investing.com - Investing.com Australia
CapsoVision, Inc.: Fundamental Analysis and Financial Ratings | H6U | US1409351079 - marketscreener.com
CapsoVision Raises Capital and Refocuses Colon Capsule Strategy - TipRanks
CapsoVision closes $14 million private placement financing - Investing.com
CapsoVision Raises ~$14 Million in Private Placement, Selling 2.87M Shares at $4.883 - tradingview.com
CapsoVision (NASDAQ: CV) secures $14M and pivots colon capsule strategy - stocktitan.net
CapsoVision Announces $14 Million Private Placement Financing - GlobeNewswire
CapsoVision, Inc.: Fundamental Analysis and Financial Ratings | CV | US1409351079 - marketscreener.com
What Is CapsoVision's Roadmap For Growth And Innovation In 2026? - RTTNews
CapsoVision Inc Trading Resumes - MSN
CapsoVision, Inc. Announces Amendment to Sample Purchase Agreement with Canon Inc. for CMOS Image Sensor Development 5 - Minichart
CapsoVision increases development fee in amended agreement with Canon By Investing.com - Investing.com South Africa
CapsoVision increases development fee in amended agreement with Canon - Investing.com
CapsoVision Amends Canon Agreement for Upgraded Image Sensors - TipRanks
CapsoVision (NASDAQ: CV) adds $1M to Canon CMOS sensor deal - Stock Titan
Analyzing CapsoVision (CV) and Its Peers - Defense World
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026 - Bitget
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):